Low c-Kit expression identifies primitive, therapy-resistant CML stem cellsMansi Shah(University of Alabama at Birmingham), Ravi Bhatia(City Of Hope National Medical Center)JCI InsightNovember 22, 202210.1172/jci.insight.157421Cited by 9SaveCiteExport RISWatch citationsRelated PapersEffective and selective inhibition of chronic myeloid leukemia primitive hematopoietic progenitors by the dual Src/Abl kinase inhibitor SKI-606|Blood|2007|105Effects of Dasatinib on Src Kinase Activity and Downstream Intracellular Signaling in Primitive Chronic Myelogenous Leukemia Hematopoietic Cells|Cancer Research|2008|99Role of BCR/ABL gene-expression levels in determining the phenotype and imatinib sensitivity of transformed human hematopoietic cells|Blood|2007|59Microenvironmental CXCL12 deletion enhances Flt3-ITD acute myeloid leukemia stem cell response to therapy by reducing p38 MAPK signaling|Leukemia|2022|30